Index - 2021

Ad26.COV2-S-vaccin AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 Aktiprol® amisulpride 202121-28 antipsychotica 202121-28 bijwerkingen 202121-28 meta-analyse 202121-28 netwerk meta-analyse 202121-28 amisulpride Aktiprol® 202121-28 antipsychotica 202121-28 bijwerkingen 202121-28 meta-analyse 202121-28 netwerk meta-analyse 202121-28 angina CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 antipsychotica Aktiprol® 202121-28 amisulpride 202121-28 bijwerkingen 202121-28 meta-analyse 202121-28 netwerk meta-analyse 202121-28 aritmie atrium flutter 202117-20 atriumfibrilleren 202117-20 hartritmestoornis 202117-20 medisch hulpmiddel 202117-20 medische app 202117-20 screening 202117-20 AstraZenica Ad26.COV2-S-vaccin 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 atrium flutter aritmie 202117-20 atriumfibrilleren 202117-20 hartritmestoornis 202117-20 medisch hulpmiddel 202117-20 medische app 202117-20 screening 202117-20 atriumfibrilleren aritmie 202117-20 atrium flutter 202117-20 hartritmestoornis 202117-20 medisch hulpmiddel 202117-20 medische app 202117-20 screening 202117-20 beroerte CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 beschermingsduur COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 bijwerkingen Aktiprol® 202121-28 amisulpride 202121-28 antipsychotica 202121-28 epidemiologisch onderzoek 20215-7 meta-analyse 202121-28 netwerk meta-analyse 202121-28 post-marketing surveillance 20215-7 registratieonderzoek 20215-7 vaccins 20215-7 vaccinvigilantie 20215-7 CanSino Ad26.COV2-S-vaccin 2021 AstraZenica 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 cardiovasculair CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 cerebrovasculair CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 ChAdOx1-S-vaccin Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 clopidogrel CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 Comirnaty COVID-19 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 covid Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid-19 2021 pandemie 2021 vaccin 2021 covid-19 Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 pandemie 2021 vaccin 2021 COVID-19 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 CVA LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 CYP2C19 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 cytochroom P450 CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 doelgroep COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 epidemiologisch onderzoek bijwerkingen 20215-7 post-marketing surveillance 20215-7 registratieonderzoek 20215-7 vaccins 20215-7 vaccinvigilantie 20215-7 ezetimib CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 genotypering CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 hartritmestoornis aritmie 202117-20 atrium flutter 202117-20 atriumfibrilleren 202117-20 medisch hulpmiddel 202117-20 medische app 202117-20 screening 202117-20 hersenbloeding CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 herseninfarct CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 intermediate metabolizer CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 Janssen Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 LDL-cholesterol CVA 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 leverenzymen CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 medisch hulpmiddel aritmie 202117-20 atrium flutter 202117-20 atriumfibrilleren 202117-20 hartritmestoornis 202117-20 medische app 202117-20 screening 202117-20 medische app aritmie 202117-20 atrium flutter 202117-20 atriumfibrilleren 202117-20 hartritmestoornis 202117-20 medisch hulpmiddel 202117-20 screening 202117-20 messenger-RNA COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 meta-analyse Aktiprol® 202121-28 amisulpride 202121-28 antipsychotica 202121-28 bijwerkingen 202121-28 netwerk meta-analyse 202121-28 Moderna COVID-19 202113-16 Comirnaty 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 mRNA COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 myocardinfarct CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 netwerk meta-analyse Aktiprol® 202121-28 amisulpride 202121-28 antipsychotica 202121-28 bijwerkingen 202121-28 meta-analyse 202121-28 P2Y12-remmers CYP2C19 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 pandemie Ad26.COV2-S-vaccin 2021 AstraZenica 2021 COVID-19 202113-16 CanSino 2021 ChAdOx1-S-vaccin 2021 Comirnaty 202113-16 Janssen 2021 Moderna 202113-16 SARS-CoV-2 202113-16 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 beschermingsduur 202113-16 covid 2021 covid-19 2021 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 vaccin 2021 virusmutatie 202113-16 PCI CYP2C19 20219-12 P2Y12-remmers 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 percutane coronaire interventie CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 poor metabolizer CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 post-marketing surveillance bijwerkingen 20215-7 epidemiologisch onderzoek 20215-7 registratieonderzoek 20215-7 vaccins 20215-7 vaccinvigilantie 20215-7 prasugrel CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 registratieonderzoek bijwerkingen 20215-7 epidemiologisch onderzoek 20215-7 post-marketing surveillance 20215-7 vaccins 20215-7 vaccinvigilantie 20215-7 revascularisatie CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 richtlijnen CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 statinen 20211-4 streefwaarden 20211-4 SARS-CoV-2 COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 screening aritmie 202117-20 atrium flutter 202117-20 atriumfibrilleren 202117-20 hartritmestoornis 202117-20 medisch hulpmiddel 202117-20 medische app 202117-20 Sputnik Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Vaxzevria® 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 statinen CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 streefwaarden 20211-4 stentplaatsing CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stents 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 stents CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 ticagrelor 20219-12 tromboseprofylaxe 20219-12 streefwaarden CVA 20211-4 LDL-cholesterol 20211-4 TIA 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 TIA CVA 20211-4 LDL-cholesterol 20211-4 angina 20211-4 beroerte 20211-4 cardiovasculair 20211-4 cerebrovasculair 20211-4 ezetimib 20211-4 hersenbloeding 20211-4 herseninfarct 20211-4 myocardinfarct 20211-4 revascularisatie 20211-4 richtlijnen 20211-4 statinen 20211-4 streefwaarden 20211-4 ticagrelor CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 tromboseprofylaxe 20219-12 tozinameran COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16 virusmutatie 202113-16 tromboseprofylaxe CYP2C19 20219-12 P2Y12-remmers 20219-12 PCI 20219-12 clopidogrel 20219-12 cytochroom P450 20219-12 genotypering 20219-12 intermediate metabolizer 20219-12 leverenzymen 20219-12 percutane coronaire interventie 20219-12 poor metabolizer 20219-12 prasugrel 20219-12 stentplaatsing 20219-12 stents 20219-12 ticagrelor 20219-12 uitwisselbaarheid COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 vaccin 202113-16 virusmutatie 202113-16 vaccin Ad26.COV2-S-vaccin 2021 AstraZenica 2021 COVID-19 202113-16 CanSino 2021 ChAdOx1-S-vaccin 2021 Comirnaty 202113-16 Janssen 2021 Moderna 202113-16 SARS-CoV-2 202113-16 Sputnik 2021 Vaxzevria® 2021 Vectorvaccins 2021 beschermingsduur 202113-16 covid 2021 covid-19 2021 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 pandemie 2021 tozinameran 202113-16 uitwisselbaarheid 202113-16 virusmutatie 202113-16 vaccins bijwerkingen 20215-7 epidemiologisch onderzoek 20215-7 post-marketing surveillance 20215-7 registratieonderzoek 20215-7 vaccinvigilantie 20215-7 vaccinvigilantie bijwerkingen 20215-7 epidemiologisch onderzoek 20215-7 post-marketing surveillance 20215-7 registratieonderzoek 20215-7 vaccins 20215-7 Vaxzevria® Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vectorvaccins 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 Vectorvaccins Ad26.COV2-S-vaccin 2021 AstraZenica 2021 CanSino 2021 ChAdOx1-S-vaccin 2021 Janssen 2021 Sputnik 2021 Vaxzevria® 2021 covid 2021 covid-19 2021 pandemie 2021 vaccin 2021 virusmutatie COVID-19 202113-16 Comirnaty 202113-16 Moderna 202113-16 SARS-CoV-2 202113-16 beschermingsduur 202113-16 doelgroep 202113-16 mRNA 202113-16 messenger-RNA 202113-16 pandemie 202113-16 tozinameran 202113-16 uitwisselbaarheid 202113-16 vaccin 202113-16